|Bid||1.7100 x 1000|
|Ask||1.7300 x 3100|
|Day's Range||1.6842 - 1.7500|
|52 Week Range||1.4300 - 3.2400|
|Beta (5Y Monthly)||1.22|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 12, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.90|
Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the Raymond James 2021 Virtual Human Health Innovation Conference on Monday, June 21, 2021 at 1:20 p.m. Eastern Time.
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Leap Therapeutics, Inc. (LPTX) delivered earnings and revenue surprises of -9.09% and -3.85%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?